Sebastian Köhler

Sebastian Köhler

Auto-generated profile, based on publicly available information

Sebastian Köhler

Ada Health GmbH

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SKSebastian Köhler
Sebastian Köhler
SBSebastian Bauer
Sebastian Bauer
DHDenise Horn
Denise Horn
PRPeter N. Robinson
Peter N. Robinson

1 November 2008 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
PRPeter N. Robinson
Peter N. Robinson
SKSebastian Köhler
Sebastian Köhler
SBSebastian Bauer
Sebastian Bauer
Dominik SeelowDominik Seelow
Dominik Seelow
DHDenise Horn
Denise Horn
SMStefan Mundlos
Stefan Mundlos

11 November 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SKSebastian Köhler
Sebastian Köhler
SDSandra C. Doelken
Sandra C. Doelken
CMChristopher J. Mungall
Christopher J. Mungall
SBSebastian Bauer
Sebastian Bauer
HFHelen V. Firth
Helen V. Firth
PRPeter N. Robinson
Peter N. Robinson
The Human Phenotype Ontology (HPO) project, available at http://www.human-phenotype-ontology.org, provides a structured, comprehensive and well-defined set of 10,088 classes (terms) describing human phenotypic abnormalities and 13,326 subclass relations between the HPO classes. In addition we have developed logical definitions for 46% of all HPO classes using terms from ontologies for anatomy, cell types, function, embryology, pathology and other domains. This allows interoperability with several resources, especially those containing phenotype information on model organisms such as mouse and zebrafish. Here we describe the updated HPO database, which provides annotations of 7,278 human hereditary syndromes listed in OMIM, Orphanet and DECIPHER to classes of the HPO. Various meta-attributes such as frequency, references and negations are associated with each annotation. Several large-scale projects worldwide utilize the HPO for describing phenotype information in their datasets. We have therefore generated equivalence mappings to other phenotype vocabularies such as LDDB, Orphanet, MedDRA, UMLS and phenoDB, allowing integration of existing datasets and interoperability with multiple biomedical resources. We have created various ways to access the HPO database content using flat files, a MySQL database, and Web-based tools. All data and documentation on the HPO project can be found online.

22 November 2018 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SKSebastian Köhler
Sebastian Köhler
LCLeigh Carmody
Leigh Carmody
NVNicole Vasilevsky
Nicole Vasilevsky
JJJulius O B Jacobsen
Julius O B Jacobsen
DDDaniel Danis
Daniel Danis
PRPeter N. Robinson
Peter N. Robinson
The Human Phenotype Ontology (HPO)—a standardized vocabulary of phenotypic abnormalities associated with 7000+ diseases—is used by thousands of researchers, clinicians, informaticians and electronic health record systems around the world. Its detailed descriptions of clinical abnormalities and computable disease definitions have made HPO the de facto standard for deep phenotyping in the field of rare disease. The HPO’s interoperability with other ontologies has enabled it to be used to improve diagnostic accuracy by incorporating model organism data. It also plays a key role in the popular Exomiser tool, which identifies potential disease-causing variants from whole-exome or whole-genome sequencing data. Since the HPO was first introduced in 2008, its users have become both more numerous and more diverse. To meet these emerging needs, the project has added new content, language translations, mappings and computational tooling, as well as integrations with external community data. The HPO continues to collaborate with clinical adopters to improve specific areas of the ontology and extend standardized disease descriptions. The newly redesigned HPO website (www.human-phenotype-ontology.org) simplifies browsing terms and exploring clinical features, diseases, and human genes.

1 October 2009 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SKSebastian Köhler
Sebastian Köhler
MSMarcel Schulz
Marcel Schulz
PKPeter Krawitz
Peter Krawitz
SBSebastian Bauer
Sebastian Bauer
SDSandra Dölken
Sandra Dölken
PRPeter N. Robinson
Peter N. Robinson

11 November 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MGMichael A Gargano
Michael A Gargano
NMNicolas Matentzoglu
Nicolas Matentzoglu
BCBen Coleman
Ben Coleman
EAEunice B Addo-Lartey
Eunice B Addo-Lartey
AAAnna V Anagnostopoulos
Anna V Anagnostopoulos
PRPeter N. Robinson
Peter N. Robinson
The Human Phenotype Ontology (HPO) is a widely used resource that comprehensively organizes and defines the phenotypic features of human disease, enabling computational inference and supporting genomic and phenotypic analyses through semantic similarity and machine learning algorithms. The HPO has widespread applications in clinical diagnostics and translational research, including genomic diagnostics, gene-disease discovery, and cohort analytics. In recent years, groups around the world have developed translations of the HPO from English to other languages, and the HPO browser has been internationalized, allowing users to view HPO term labels and in many cases synonyms and definitions in ten languages in addition to English. Since our last report, a total of 2239 new HPO terms and 49235 new HPO annotations were developed, many in collaboration with external groups in the fields of psychiatry, arthrogryposis, immunology and cardiology. The Medical Action Ontology (MAxO) is a new effort to model treatments and other measures taken for clinical management. Finally, the HPO consortium is contributing to efforts to integrate the HPO and the GA4GH Phenopacket Schema into electronic health records (EHRs) with the goal of more standardized and computable integration of rare disease data in EHRs.